(1)
The fund is part of Tikehau Capital s private debt platform and will focus on corporate impact lending
The European Investment Fund is one of the main investors, using resources from the European Fund for Strategic Investments (EFSI), the main pillar of the Investment Plan for Europe.
Regulatory News:
Tikehau Capital (Paris:TKO), the alternative asset management and investment group has completed the first closing for its investment platform focused on impact lending, raising c. €100 million from the European Investment Fund, backed by the Investment Plan for Europe, an anchor investor alongside other key institutional investors.
Tikehau Capital intends to contribute to a sustainable European economy while providing investors with competitive returns by investing primarily in European SMEs which contribute to the sustainable economic transition in Europe through their offering, their resource management, or their processes.
Share this article
Share this article
MADRID, Feb. 10, 2021 /PRNewswire/ MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced today that it has closed an upsized EUR 18 million (USD 21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board of Directors. MedLumics optical catheter displays lesion creation in real-time providing the physician with direct visual confirmation of conduction tissue denaturation.
Kurma Partners joined the round which includes and was initially led by Asabys Partners, along with new investors, VI Partners Swiss Innovation and CDTI Innvierte Economía, and existing investors Andera Partners, Caixa Capital Risc and Innogest Capital II. Having achieved pre-clinical feasibility in 2020, these proceeds will now enable MedLumics to initiate first in-human regulatory clinical studies and automa
EIB Group signed 27 operations in Portugal in 2020
The measures taken by the EIB to mitigate the effects of the pandemic focused on two main areas: the healthcare sector and small and medium-sized enterprises (SMEs). EIB | Lisbon | Updated: 09-02-2021 22:33 IST | Created: 09-02-2021 22:33 IST
Overall financing from the EIB Group in 2020 reached €76.8 billion (an increase of 6% compared to 2019), with €66.09 billion provided in the form of loans from the EIB and €12.87 billion released via the EIF, the subsidiary of the EIB. Image Credit: Flickr
The European Investment Bank Group (EIB and EIF) signed 27 operations in Portugal in 2020 for a total financing volume of €2.336 billion, an increase of 44% compared to 2019, and accounting for around 1.2% of the country s GDP. Overall, Portugal was, of all EU countries, the 4th largest beneficiary of EIB Group support as a percentage of GDP.
Covid-19 in Bulgaria: Day 338 published on 2/8/21 7:25 PM
Photo: BTA
Health authorities in Bulgaria decide to accelerate vaccination against Covid-19
All delivered quantities of the AstraZeneca vaccine should be used for administering the first dose of the vaccination, Bulgaria s National Vaccine Task Force decided. This will cover larger groups of the population and will speed up immunization. The vaccine body will recommend that medical professionals administer the second dose of the vaccine 10 weeks after the first.
The members of the vaccination authorities expressed the opinion that the Oxford vaccine can be used for vaccination of all Bulgarian citizens over 18 years of age, the Bulgarian Ministry of Health announced.